Human cardiac mast cells in anaphylaxis.

Human heart mast cells (HHMC), by elaborating vasoactive mediators, cytokines and chemokines, are the main primary effector cells of anaphylaxis. Mast cells have been identified perivascularly, close to myocytes and in the arterial intima in human heart tissue. Mast cells isolated from human heart tissue (HHMC) of patients undergoing cardiac transplantation express high-affinity receptors for IgE (FcepsilonRI) and C5a receptors. Activation of HHMC in vitro with anti-IgE or anti-FcepsilonRI induced the release of preformed mediators (histamine, tryptase, chymase, and renin) and the de novo synthesis of LTC(4) (approximately =18 ng/l0(6) cells) and PGD(2) (approximately =18 ng/l0(6) cells). Complement is activated and anaphylatoxin forms during anaphylaxis. C5a causes rapid release of histamine and tryptase from HHMC. These cells are activated in vitro by therapeutic (general anesthetics, protamine, etc.) and diagnostic agents (radiocontrast media, etc.) which can cause anaphylactoid reactions. Low concentrations of histamine and cysteinyl leukotrienes given to subjects undergoing diagnostic catheterization caused significant systemic and coronary hemodynamic effects. These results indicate that HHMC probably have a role in anaphylactic reactions.

[1]  S. Kano,et al.  Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. , 2006, The Journal of clinical investigation.

[2]  D. Herzlinger,et al.  Mast cells: a unique source of renin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Lockey,et al.  Anaphylaxis: a review of causes and mechanisms. , 2002, The Journal of allergy and clinical immunology.

[4]  Sandy J. Wilson,et al.  Decreased intracellular calcium mediates the histamine H3-receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Saito,et al.  Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells. , 2001, Biochemical and biophysical research communications.

[6]  T. Lovenberg,et al.  Coupling of histamine H3 receptors to neuronal Na+/H+ exchange: A novel protective mechanism in myocardial ischemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Y. Masuho,et al.  Molecular Cloning and Characterization of a Novel Type of Histamine Receptor Preferentially Expressed in Leukocytes* , 2000, The Journal of Biological Chemistry.

[8]  P. Kovanen,et al.  Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries. , 2000, Circulation.

[9]  F. Granata,et al.  Immunological Modulation of Human Cardiac Mast Cells , 1999, Neurochemical Research.

[10]  E. Arbustini,et al.  Stem cell factor is localized in, released from, and cleaved by human mast cells. , 1999, Journal of immunology.

[11]  B. Milne,et al.  Latex anaphylaxis causing heart block: role of ranitidine , 1999, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[12]  Y. Kihara,et al.  New insights into the pathophysiological role for cytokines in heart failure. , 1999, Cardiovascular research.

[13]  P. Gérard,et al.  Mechanisms of severe, immediate reactions to iodinated contrast material. , 1998, Radiology.

[14]  E. Arbustini,et al.  Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. , 1998, Circulation.

[15]  G. Marone,et al.  Heterogeneous effects of protamine on human mast cells and basophils. , 1997, British journal of anaesthesia.

[16]  P. Kovanen,et al.  Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. , 1996, Circulation.

[17]  A. Pietroiusti,et al.  Paroxysmal atrial fibrillation after insect sting. , 1996, The Journal of allergy and clinical immunology.

[18]  G. Marone,et al.  Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator release. , 1996, The Journal of allergy and clinical immunology.

[19]  H. Lander,et al.  Activation of histamine H3-receptors inhibits carrier-mediated norepinephrine release during protracted myocardial ischemia. Comparison with adenosine A1-receptors and alpha2-adrenoceptors. , 1996, Circulation research.

[20]  D. Mann,et al.  Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart , 1996 .

[21]  O. Febo,et al.  Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. , 1995, Circulation.

[22]  H. Lander,et al.  Functional identification of histamine H3-receptors in the human heart. , 1995, Circulation research.

[23]  G. Marone,et al.  Human heart mast cells: a definitive case of mast cell heterogeneity. , 1995, International archives of allergy and immunology.

[24]  E. Arbustini,et al.  Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. , 1995, Journal of immunology.

[25]  P. Kovanen,et al.  Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. , 1994, Circulation.

[26]  P. Kovanen,et al.  Mast cells of two types differing in neutral protease composition in the human aortic intima. Demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[27]  R. Levi,et al.  Histamine H3-receptor signaling in the heart: possible involvement of Gi/Go proteins and N-type Ca++ channels. , 1994, The Journal of pharmacology and experimental therapeutics.

[28]  J. Kochan,et al.  Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. , 1993, The New England journal of medicine.

[29]  R. Klasco.  Fatal and near-fatal anaphylactic reactions to food in children and adolescents: Sampson HA, Mendelson L, Rosen JP N Engl J Med 327:380–384 Aug 1992 , 1993 .

[30]  H. Sampson,et al.  Fatal and near-fatal anaphylactic reactions to food in children and adolescents. , 1992, The New England journal of medicine.

[31]  M. Tsai,et al.  Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  K. Misono,et al.  Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. , 1990, The Journal of biological chemistry.

[33]  L. Schwartz,et al.  Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell. , 1990, Journal of immunology.

[34]  R. Patterson,et al.  Nearly fatal idiopathic anaphylactic reaction resulting in cardiovascular collapse and myocardial infarction. , 1990, Chest.

[35]  L. Puybasset,et al.  Contractile activity of three endothelins (ET‐1, ET‐2 and ET‐3) on the human isolated bronchus , 1990, British journal of pharmacology.

[36]  M. Polley,et al.  Cardiac Anaphylaxis Complement Activation As an Amplification System , 1989, Circulation research.

[37]  V. Casolaro,et al.  IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells. , 1989, The Journal of investigative dermatology.

[38]  M. Polley,et al.  Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects. , 1988, The Journal of pharmacology and experimental therapeutics.

[39]  R. Raper,et al.  PROFOUND REVERSIBLE MYOCARDIAL DEPRESSION AFTER ANAPHYLAXIS , 1988, The Lancet.

[40]  F. Rengo,et al.  Effects of histamine on coronary hemodynamics in humans: role of H1 and H2 receptors. , 1987, Journal of the American College of Cardiology.

[41]  A. Barger,et al.  Neovascularization and coronary atherosclerotic plaque: cinematographic localization and quantitative histologic analysis. , 1987, Human pathology.

[42]  D. Mathey,et al.  Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. , 1986, Journal of immunology.

[43]  Y. Hattori,et al.  Effect of PGD2 on cardiac contractility: a negative inotropism secondary to coronary vasoconstriction conceals a primary positive inotropic action. , 1986, The Journal of pharmacology and experimental therapeutics.

[44]  M. Triggiani,et al.  Effect of activation of the H1 receptor on coronary hemodynamics in man. , 1986, Circulation.

[45]  R. Virmani,et al.  Increased adventitial mast cells in a patient with coronary spasm. , 1985, The New England journal of medicine.

[46]  M. Polley,et al.  Cardiac dysfunction caused by purified human C3a anaphylatoxin. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[47]  F. Carswell.  Thirty deaths from asthma. , 1985, Archives of disease in childhood.

[48]  M. Chiariello,et al.  Cardiovascular Effects of Histamine Infusion in Man , 1983, Journal of cardiovascular pharmacology.

[49]  T. J. Sullivan.  Cardiac disorders in penicillin-induced anaphylaxis. Association with intravenous epinephrine therapy. , 1982, JAMA.

[50]  D. Baim,et al.  Coronary spasm associated with urticaria: Report of a case mimicking anaphylaxis , 1982, Clinical cardiology.

[51]  P. L. Smith,et al.  Physiologic manifestations of human anaphylaxis. , 1980, The Journal of clinical investigation.

[52]  H. Levine.  Acute myocardial infarction following wasp sting , 1976 .

[53]  R. Levi,et al.  The heart as a target organ in systemic allergic reactions: comparison of cardiac analphylaxis in vivo and in vitro. , 1975, Circulation research.

[54]  C. Delage,et al.  Anaphylactic deaths: a clinicopathologic study of 43 cases. , 1972, Journal of forensic sciences.

[55]  Criep Lh,et al.  The heart in human anaphylaxis. , 1971 .

[56]  R. Patterson,et al.  Electrocardiographic changes during human anaphylaxis. , 1970, JAMA.

[57]  M. Weil,et al.  Anaphylactic shock in man. Report of two cases with detailed hemodynamic and metabolic studies. , 1967, Archives of internal medicine.

[58]  M. Bernreiter.  Electrocardiogram of patient in anaphylactic shock. , 1959, Journal of the American Medical Association.

[59]  Michael Schwenk,et al.  Anaphylaxis , 1919, The Indian medical gazette.

[60]  M. Jackson,et al.  Cloning and Functional Expression of the Human Histamine H 3 Receptor , 1999 .

[61]  F. Rengo,et al.  Metabolic and hemodynamic effects of peptide leukotriene C4 and D4 in man , 1997, International journal of clinical & laboratory research.

[62]  G. Marone,et al.  Modulation of Human Lung Mast Cell Function by the c-kit Receptor Ligand. , 1992, International archives of allergy and immunology.

[63]  S. Galli,et al.  Effect of Recombinant Human c-kit Receptor Ligand on Mediator Release from Human Skin Mast Cells. , 1992, International Archives of Allergy and Immunology.

[64]  L. Lichtenstein,et al.  CURRENT CONCEPTS : ANAPHYLAXIS , 1991 .

[65]  M. Triggiani,et al.  Chemical mediators and the human heart. , 1985, Progress in biochemical pharmacology.

[66]  T. Woehler,et al.  The heart in human anaphylaxis. , 1971, Annals of allergy.

[67]  M. Jackson,et al.  Cloning and functional expression of the human histamine H3 receptor. , 1999, Molecular pharmacology.